Company Filing History:
Years Active: 2025
Title: Marie-Pierre Collin-Kröpelin: Innovator in Medicinal Chemistry
Introduction
Marie-Pierre Collin-Kröpelin is a distinguished inventor based in Weil am Rhein, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating various diseases. Her innovative work has led to the filing of a patent that addresses critical health issues.
Latest Patents
Marie-Pierre holds a patent for "Substituted pyrazolo piperidine carboxylic acids." This invention relates to substituted pyrazolo piperidine carboxylic acids, their salts, and processes for their preparation. The patent also covers their use in preparing medicaments for the treatment and/or prophylaxis of diseases, including cardiovascular and cardiac diseases, hypertension, and neurodegenerative diseases. This work is particularly relevant for conditions such as heart failure, chronic kidney disease, and pulmonary hypertension.
Career Highlights
Marie-Pierre is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. Her role involves extensive research and development in the field of medicinal chemistry. She has demonstrated a strong commitment to advancing healthcare through her innovative approaches to drug development.
Collaborations
Marie-Pierre has collaborated with notable colleagues, including Alexandros Vakalopoulos and Nuria Ortega Hernandez. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Marie-Pierre Collin-Kröpelin is a prominent figure in the field of medicinal chemistry, with a focus on developing innovative solutions for serious health conditions. Her contributions through patents and collaborations highlight her dedication to improving patient outcomes.